Slides
Page 1
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben
Page 2
2026 October 29, 2026 Q3 ANDREAS NIEDERMAIER, CEO ANDREAS LÖSLER, CFO
Page 3
CAUTIONARY NOTE REGARDING FORWARD - LOOKING STATEMENTS This presentation contains forward - looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available information and present estimates. They are subject to a multitude of uncertainties and risks. Actual business development may therefore differ materially from what has been expected. Beyond disclosure requirements stipulated by law, Alzchem does not undertake any obligation to update forward - looking statements. Unless stipulated otherwise, all values are rounded up or down in accordance with the commercial rounding practices. Please note that differences can result from the use of rounded amounts and percentages. DISCLAIMER
Page 4
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q3 2026
Page 5
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben HIGHLIGHTS Alzchem is on expected growth level and confirms outlook © Alzchem Group AG / October 2026 ✓ ✓ ✓ 5 Strong performance on group level : + 4% revenue growth + 8 % EBITDA growth Specialty Chemicals remains the key growth and earnings driver Basics & Intermediates impacted by lower volumes Nitroguanidine expansion in Germany reaches technical start - up Carbide furnace successfully back into operation S hare buyback program successfully completed New program to follow with € 20m volume 2026 Outlook confirmed – Alzchem on growth path Major growth expansions are progressing • Creatin capacity expansion in Germany as scheduled • U.S. Nitroguanidin plant with cost and planning optimization underway
Page 6
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q3 2026
Page 7
BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of specialty chemicals.
Page 8
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BASICS & INTERMEDIATES SEGMENT ( in M €) Sales and EBITDA development on expected level 8 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 1.8 4.1 0.1 1.2 3.8 0.5 0.3 - 0.3 2.0 - 46.0% SALES EBITDA 1 - 9 2025 1 - 9 2026 5.1 2.0 - 60.4% 1 - 9 2025 1 - 9 2026 121.6 109.5 - 9.9% SALES EBITDA COMMENTS SALES ANALYSIS • Expected decline in revenue primarily due to lower sales volumes • Ongoing weak demand in agriculture and continued price pressure from Asian competitors in the pharmaceutical industry • Positive impact from metallurgical business due to improved economic situation in the steel industry • EBITDA impacted by high electricity and raw material prices • Inventories reduced significantly after planned stock build - up in 2025 - 17.8% - 3.6% + 0.2% DELTA Q3 DELTA 01 - 09 - 7.8% - 1.9% - 0.2% Volume Price Currency Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 40.9 41.9 42.6 35.6 43.3 33.5 36.7 38.7 34.1 - 21.2% © Alzchem Group AG / October 2026
Page 9
SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high - quality specialty chemical ingredients with strong growth perspectives.
Page 10
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben SPECIALTY CHEMICALS SEGMENT ( in M €) Ingredients for Specialty Applications push Sales and EBITDA 10 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 80.4 89.0 94.5 100.1 87.0 97.2 105.3 109.0 98.5 +13.2% Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 21.7 26.7 26.0 27.9 24.1 28.8 31.5 32.6 27.5 +13.9% SALES EBITDA 1 - 9 2025 1 - 9 2026 78.0 91.5 +17.4% 1 - 9 2025 1 - 9 2026 281.6 312.7 +11.1% SALES EBITDA COMMENTS SALES ANALYSIS • Specialty Chemicals expected key growth driver with positive volume and price effects • Sales increased by 11% to EUR 313m • Main sustainable growth areas: • Human Nutrition, • Defense • Custom Manufacturing • Creatine growth supported by last years capacity increase • Sales development leads to EBITDA growth and EBITDA margin increase + 6.4% + 5.9% + 0.9% DELTA Q3 DELTA 01 - 09 + 5.1% + 6.9% - 1.0% Volume Price Currency © Alzchem Group AG / October 2026
Page 11
OTHER & HOLDING The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers.
Page 12
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OTHER & HOLDING SEGMENT ( in M €) Regulated grid fees impact sales and result 12 SALES EBITDA 1 - 9 2025 1 - 9 2026 1.0 0.1 - 84.5% 1 - 9 2025 1 - 9 2026 21.7 21.6 - 0.4% SALES EBITDA COMMENTS • Sales broadly stable year - on - year with slight decline driven by lower electricity grid fee pass - throughs • Q3 revenue increased due to higher demand from chemical park customers and increased electricity grid fees • EBITDA impacted by infrastructure modernization measures Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 7.7 8.1 7.5 7.1 7.0 6.6 6.7 7.6 7.3 +4.3% © Alzchem Group AG / October 2026 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 1.1 - 0.7 0.3 0.1 0.6 - 0.3 0.2 - 0.5 0.5 - 22.9%
Page 13
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FINANCIAL OVERVIEW 13 • Sales increased to EUR 444m, while EBITDA margin improved from 20.3% to 21.0% • Volume and price increases as key drivers for positive sales trend • Higher sales portion of specialty products combined with sustained cost discipline resulted in a substantial improvement in EBITDA and EBITDA margin • Energy and raw material costs with volatile development – price increases are being rolled out • Higher depreciation charges after commissioning of new facilities reflect the increased level of investment activity • Net result and earnings per share follow strong operating performance, but impacted by deprecation and financial result © Alzchem Group AG / October 2026 Strong full - year performance with growth in all KPI Q3 Q3 2025 2026 2025 2026 1 - 9 1 - 9 SALES (in M€) 137.3 139.9 +1.9% 424.8 443.8 +4.5% EBITDA (in M€) 29.7 28.7 -3.5% 86.2 93.2 +8.1% EBITDA margin (in %) 21.7% 20.5% -1.1pp 20.3% 21.0% +0.7 pp Earnings per Share (in €) 1.61 1.34 -17.0% 4.62 4.77 +3.2% qoq % Alzchem Group yoy % SALES ANALYSIS DELTA Q3 DELTA 01 - 09 Volume -1.5% +1.0% Price +2.8% +4.2% Currency +0.6% -0.7%
Page 14
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BALANCE SHEET & CASHFLOW Balance sheet total shows the current growth CAPEX projects © Alzchem Group AG / October 2026 14 • Increase in balance sheet tota l resulting from increased CAPEX • Inventories further reduced following the carbide furnace refurbishment • Stable equity ratio despite increase in balance sheet total • €6m r educed pension obligation as interest increased • Adjusted for customer payments ( - € 44m), operating cash flow was significantly stronger than in the previous year • Investing cash flow increased significantly year - on - year driven by growth in defense and human nutrition as well as the replacement of the carbide furnace. • Free cash flow turned negative year - on - year driven by significantly higher growth investments • Financial cashflow impacted by new financing structure, dividend payments and share buyback program COMMENTS Balance sheet KPIs (T€) 31.12.2025 30.09.2026 Deviation Balance sheet total 617,679 673,711 56,032 9.1% Inventories 116,004 104,581 11,423 - -9.8% Equity 258,231 280,590 22,359 8.7% Equity ratio 41.8% 41.6% -0.2 pp -0.1% Liabilities to Banks 41,118 86,299 45,181 109.9% Cash and cash equivalents 71,720 63,845 7,876 - -11.0% Net financial debt (-) / asset (+) 30,602 22,455 - 53,057 - -173.4% Cashflow KPIs (T€) 1 - 9 2025 1 - 9 2026 Deviation Operating Cashflow 115,497 97,387 18,111 - -15.7% Investing Cashflow 67,430 - 117,570 - 50,140 - 74.4% Free Cashflow 48,067 20,183 - 68,250 - -142.0% Financial Cashflow 29,404 - 12,327 41,731 141.9% Net increase in cash 18,663 7,856 - 26,519 - -142.1% Cash / Assets Other receivables Contract liabilities 69.9 93.2 23.3 KPI impact of nitroguanidine expansion in total on balance sheet in M €
Page 15
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUTLOOK 2026 ( in M €) Ongoing growth in sales and EBITDA on expected level 15 COMMENTS Outlook for 2026 confirmed Major assumptions are still valid • Possible cost increases in energy and raw materials shall be passed through to customers • No additional impact from the Iran conflict; long - term disruption of global supply chains is not included in the outlook Sales Growth • Growth solely coming from ingredients in segment Specialty Chemicals • Basics & Intermediates: Sales remain slightly below previous year’s level • Organic growth, no acquisitions EBITDA Growth • Further increase in specialty chemical sales will increase EBITDA as well • Volume and price increases support EBITDA 2020 FC 2021 53.8 Stable to s lightly rising 57.0 R ising to strong rising 2025 FC 2026 (Q2) 126.0 FC 2026 (Q3) 116.5 +8% 2025 FC 2026 (Q2) 600.0 FC 2026 (Q3) 562.1 +7% SALES EBITDA growth to approx. 600 .0 M € growth to approx. 126 M € © Alzchem Group AG / October 2026
Page 16
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FINANCIAL CALENDAR Upcoming dates* 16 *subject to change Financial calender ALL DATES AT A GLANCE OCT 29 2026 Quarterly Statement 3rd Quarter 2026 NOV 12 - 13 2026 Jefferies Roadshow, New York, Boston NOV 23 - 24 2026 Deutsches Eigenkapitalforum , Frankfurt NOV 26 - 27 2026 Berenberg Roadshow, Stockholm DEC 1 2026 Berenberg European Conference, London DEC 10 2026 MPCM Exclusive Company Evening, Frankfurt FEB 25 2027 Annual Report 2026 MAR 4 2027 EU Opportunities Conference, London MAR 23 2027 J.P. Morgan European Chemicals Forum, London APR 29 2027 Quarterly Statement 1st Quarter 2027 MAY 5 2027 Annual General Meeting MAY 27 2027 Berenberg European Conference, Manhattan JUL 29 2027 Half - year Financial Report 2027 OCT 28 2027 Quarterly Statement 3rd Quarter 2027
Page 17
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben FEEDBACK We appreciate your feedback 17 Were your expectations met? Are you missing any content? WE APPRECIATE YOUR FEEDBACK! Link QR - Code
Page 18
AGILE SCIENCE PURE RESULTS www.alzchem.com Investor Relations T +49 8621 86 - 2888 F +49 8621 86 - 502888 ir@alzchem.com
Page 19
I. Executive Summary II. Business and financial details III. Back - Up AGENDA – ANALYST PRESENTATION Q3 2026
Page 20
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben KPI IMPACT OF CUSTOMER GRANTS Timing and effects on balance sheet and P&L 21 © Alzchem Group AG / October 2026 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 EST KEY EFFECTS 1 1) Only customer investment contribution / 2) Based on our current best estimate and ongoing negotiations contract liablities other receiveables receivables liabilities Sales / EBITDA effect KPI EFFECTS 2025/2026 Cash / Assets ↑ Other receivables ↑ Equity → Contract liabilities ↑ Equity ratio ↓ Sales → EBITDA → KPI EFFECTS 2027 et seq. Cash / Assets → Other receivables ↓ Equity ↑ Contract liabilities ↓ Equity ratio ↑ Sales ↑ EBITDA ↑ Cash / Assets Other receivables Contract liabilities 69.9 93.2 23.3 TOTAL EFFECTS in M €
Page 21
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben BALANCE SHEET Alzchem Group 22 ALZCHEM GROUP (IN T€) 31.12.2025 30.09.2026 Deviation Intangible assets 3,530 4,018 489 13.8% Tangible assets 276,980 353,611 76,631 27.7% Investment properties Right of use (assets) 2,992 1,767 -1,224 -40.9% Investments accounted for using the equity method Financials assets 6 6 Trade receivables Other receivables 21,801 13,359 -8,441 -38.7% there of Deferred tax assets for pensions provisions Deferred tax assets 15,711 14,060 -1,651 -10.5% SUM NON-CURRENT ASSETS 321,019 386,821 65,802 20.5% Inventories 116,004 104,581 -11,423 -9.8% Trade receivables 73,416 77,371 3,955 5.4% Financial assets 0 0 0 -61.6% Other receivables 35,201 40,928 5,727 16.3% Income tax receivables 319 165 -154 -48.3% Cash and cash equivalents 71,720 63,845 -7,876 -11.0% Assets classified as held for sale Other assets SUM CURRENT ASSETS 296,660 286,890 -9,770 -3.3% SUM ASSETS 617,679 673,711 56,032 9.1% © Alzchem Group AG / October 2026 ALZCHEM GROUP (IN T€) 31.12.2025 30.09.2026 Deviation Share capital 101,763 101,763 RETAINED EARNINGS (+) / LOSS (-) 232,111 259,096 26,984 11.6% Other comprehensive income -12,398 -7,111 5,287 -42.6% Own shares -4,111 -14,148 -10,036 244.1% SHARE TO THE SHAREHOLDERS 256,296 278,528 22,231 8.7% Non-controlling interests 1,934 2,063 128 6.6% SUM EQUITY 258,231 280,590 22,359 8.7% Provisions for pensions 88,239 81,971 -6,268 -7.1% Other provisions 18,981 19,568 587 3.1% Loans 34,750 76,875 42,125 121.2% Finance lease liabilities 1,239 436 -803 -64.8% Trade liabilities 14 -14 -100.0% Contract liabilities 88,099 84,754 -3,345 -3.8% Other liabilities 492 702 210 42.6% Deferred tax liabilities 8,730 10,417 1,687 19.3% SUM NON-CURRENT LIABILITIES 240,543 274,722 34,179 14.2% Other provisions 7,190 5,021 -2,169 -30.2% Loans 6,368 9,424 3,056 48.0% Finance lease liabilities 1,874 1,424 -450 -24.0% Finance liabilities 67 67 Trade liabilities 51,726 44,355 -7,371 -14.2% Contract liabilities 2,433 9,289 6,857 281.8% Other liabilities 38,340 40,046 1,706 4.4% Income tax liabilities 10,973 8,771 -2,202 -20.1% SUM CURRENT LIABILITIES 118,904 118,398 -506 -0.4% Sum EQUITY AND LIABILITIES 617,679 673,711 56,032 9.1%
Page 22
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben PENSION ACCOUNTING (IFRS) Alzchem Group (M €) 23 PENSION PROVISION 31.12.2025 +0.2 SERVICE COSTS +2.7 NET INTEREST COSTS - 2.2 PENSION PAYMENTS - 7.0 PENSION REMEASURE - MENTS PENSION PROVISION 30.09.2026 - 6.1 DEFERRED TAX ASSETS PENSION LIABILITY 30.09.2026 88.2 82.0 75.9 - 7.1% BALANCE SHEET P&L CASHFLOW IN FINANCIAL STATEMENT EBITDA (PERSONELL EXPENSES) FINANCIAL RESULT OCI © Alzchem Group AG / October 2026 • Interest rates increased from 4.1% to 4.7% • Pension payments develop as expected with 2.2 M € - pension obligation has a long maturity with approx. 30 years payout period
Page 23
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben INCOME STATEMENT Alzchem Group 24 ALZCHEM GROUP (IN T€) Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Deviation (Q3) Revenue 144,680 142,879 137,266 137,290 148,653 155,250 139,882 2,616 2% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 11,436 3,433 624 545 4,143 -11,145 -6,259 -6,882 <-1.000% Other income 5,263 5,006 3,806 9,266 7,339 6,038 6,349 2,542 67% Raw materials and consumables used -64,236 -47,293 -43,769 -42,989 -53,148 -39,986 -41,100 2,669 -6% Employee benefits expense -41,150 -44,894 -43,245 -44,322 -44,117 -47,660 -42,619 626 -1% Other expense -28,632 -30,036 -24,957 -29,494 -30,583 -30,297 -27,554 -2,597 10% EBITDA 27,362 29,096 29,724 30,296 32,286 32,199 28,698 -1,026 -3% Depreciation expense -6,552 -6,435 -6,655 -7,007 -6,701 -7,494 -9,556 -2,901 44% Impairment EBIT 20,810 22,662 23,069 23,290 25,585 24,706 19,142 -3,927 -17% Investment income Other interest and similar income 712 626 819 1,082 381 175 929 110 13% Other interest and similar expense -1,278 -1,284 -1,254 -1,314 -1,330 -1,592 -1,523 -268 21% Financial result -567 -658 -436 -232 -948 -1,417 -594 -158 36% Result from associates Result from ordinary business 20,243 22,003 22,634 23,057 24,637 23,289 18,549 -4,085 -18% Taxes on income and profit -5,607 -6,128 -6,297 -6,276 -6,636 -6,464 -5,002 1,295 -21% thereof income tax -4,537 -6,330 -5,550 -6,040 -5,754 -5,741 -4,846 704 -13% thereof change from deferred taxes -1,070 202 -748 -235 -882 -724 -156 591 -79% Annual result 14,636 15,876 16,337 16,782 18,001 16,825 13,547 -2,790 -17% thereof minority interests 43 43 43 43 43 43 43 thereof shares held by shareholders 14,594 15,833 16,294 16,739 17,958 16,782 13,504 -2,790 -17% Result per share in EUR 1.44 € 1.57 € 1.61 € 1.66 € 1.77 € 1.66 € 1.34 € © Alzchem Group AG / October 2026
Page 24
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben INCOME STATEMENT Alzchem Group 25 ALZCHEM GROUP (IN T€) Q3 2025 Q3 2026 Deviation (QoQ) YTD Sep.2025 YTD Sep.2026 Deviation (YoY) Revenue 137,266 139,882 2,616 1.9% 424,825 443,785 18,960 4.5% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 624 -6,259 -6,882 <-1.000% 15,493 -13,261 -28,754 -185.6% Other income 3,806 6,349 2,542 66.8% 14,076 19,726 5,651 40.1% Raw materials and consumables used -43,769 -41,100 2,669 -6.1% -155,297 -134,235 21,062 -13.6% Employee benefits expense -43,245 -42,619 626 -1.4% -129,289 -134,397 -5,108 4.0% Other expense -24,957 -27,554 -2,597 10.4% -83,625 -88,434 -4,810 5.8% EBITDA 29,724 28,698 -1,026 -3.5% 86,183 93,184 7,001 8.1% Depreciation expense -6,655 -9,556 -2,901 43.6% -19,642 -23,751 -4,109 20.9% Impairment 0 0 0 0 0 0 EBIT 23,069 19,142 -3,927 -17.0% 66,541 69,433 2,892 4.3% Investment income 0 0 0 0 0 0 Other interest and similar income 819 929 110 13.5% 2,156 1,485 -671 -31.1% Other interest and similar expense -1,254 -1,523 -268 21.4% -3,817 -4,444 -627 16.4% Financial result -436 -594 -158 36.3% -1,660 -2,959 -1,298 78.2% Result from associates 0 0 0 0 0 0 Result from ordinary business 22,634 18,549 -4,085 -18.0% 64,880 66,474 1,594 2.5% Taxes on income and profit -6,297 -5,002 1,295 -20.6% -18,032 -18,102 -71 0.4% thereof income tax -5,550 -4,846 704 -12.7% -16,416 -16,340 76 -0.5% thereof change from deferred taxes -748 -156 591 -79.1% -1,616 -1,762 -147 9.1% Annual result 16,337 13,547 -2,790 -17.1% 46,849 48,372 1,523 3.3% thereof minority interests 43 43 0 0.0% 128 128 0 0.0% thereof shares held by shareholders 16,294 13,504 -2,790 -17.1% 46,720 48,244 1,523 3.3% Result per share in EUR 1.61 € 1.34 € 0 -17.0% 4.62 € 4.77 € 0 3.2% © Alzchem Group AG / October 2026
Page 25
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben CASHFLOW STATEMENT Alzchem Group 26 © Alzchem Group AG / October 2026 CASHFLOW (IN M€) Q3 2025 Q3 2026 1 - 9 2025 1 - 9 2026 Consolidated earnings before taxes 22,634 18,549 64,880 66,474 Depreciation on fixed and intangible assets 6,655 9,556 19,642 23,751 Decrease in pension provisions -612 -671 -1,986 -2,160 Loss (+) / Profit (-) from the sale of non-current assets -1 42 21 5 Other non-cash income (-) and expenses (+) 892 1,437 3,161 6,899 Financial result 436 594 1,660 2,959 Interests & Taxes -4,556 -5,246 -12,442 -19,244 Increase (+) / Decrease (-) Net Working Capital 14,279 19,787 -14,977 7,275 Payments from customer grants 2,636 55,537 11,427 Cashflow from ongoing operations (Net cash flow) 44,259 46,683 115,497 97,387 Cash outflows for investments in fixed assets -26,936 -36,430 -67,471 -117,735 Cash inflows from the sale of fixed assets 1 86 41 166 Cash inflows from grants received for investments Cashflow from investing activity -26,935 -36,344 -67,430 -117,570 Free cashflow 17,324 10,338 48,067 -20,183 Deposits (+) of bank loans long-term 80,000 Repayment (-) of bank loans long-term -1,583 -1,583 -6,000 -34,750 Deposits (+) / Repayment (-) from short-term financing lines Dividend payments -18,190 -21,260 Payment of reduction in leasing liabilities -482 -486 -1,438 -1,443 Payments for the acquisition of own shares (incl. transaction costs) 0 -10,043 -3,605 -10,043 Payments for the issue of own shares 0 -6 Payments to non-controlling interests -171 -171 Cashflow from financing activity -2,065 -12,113 -29,404 12,327
Page 26
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben SEGMENT OVERVIEW BY QUARTER Alzchem Group SALES EBITDA 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q3) PY Actual Deviation PY (YOY) T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 49,299 41,848 40,927 41,929 42,638 35,605 43,309 33,539 36,666 38,684 34,115 -9,194 -21% 121,552 109,465 -12,087 -10% Specialty Chemicals 92,961 85,805 80,354 88,969 94,512 100,128 86,978 97,159 105,298 108,954 98,490 11,512 13% 281,617 312,742 31,124 11% Other and Holding 7,804 8,538 7,656 8,142 7,530 7,146 6,979 6,592 6,689 7,611 7,277 298 4% 21,655 21,578 -77 0% Group Consolidation Alzchem Group 150,064 136,191 128,937 139,040 144,680 142,879 137,266 137,290 148,653 155,250 139,882 2,616 2% 424,825 443,785 18,960 4% SALES YTD Q3 2026 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q3) PY Actual Deviation PY (YOY) T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 1,802 3,055 1,827 4,142 140 1,174 3,754 549 284 -304 2,028 -1,727 -46% 5,068 2,008 -3,060 -60% Specialty Chemicals 22,684 22,843 21,749 26,741 26,041 27,854 24,117 28,782 31,484 32,593 27,470 3,353 14% 78,012 91,548 13,536 17% Other and Holding 537 849 1,114 -711 307 50 596 -287 222 -533 460 -136 -23% 954 148 -806 -84% Group Consolidation -113 274 194 -1,717 874 18 1,257 1,253 296 443 -1,259 -2,516 -200% 2,149 -520 -2,669 -124% Alzchem Group 24,910 27,021 24,883 28,455 27,362 29,096 29,724 30,296 32,286 32,199 28,698 -1,026 -3% 86,183 93,184 7,001 8% EBITDA YTD Q3 2026 © Alzchem Group AG / October 2026
Page 27
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben ALZCHEM GROUP LOCATIONS Production sites and sales companies © Alzchem Group AG / October 2026 ATLANTA (USA) SHANGHAI (CN) SCHALCHEN (GER) HART a. d. ALZ (GER) WALDKRAIBURG (GER) SUNDSVALL (SE) TROSTBERG (GER) SALES COMPANY PRODUCTION SITE Production facilities in Germany (4) and Sweden (1) and HQ in Trostberg (GER) COVENTRY (UK) BERLIN (GER)
Page 28
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben “VERBUND” – FULLY INTEGRATED BUSINESS MODEL Vertically integrated production of chemical products based on the NCN chain BENEFITS OF “VERBUND” • Full control of product quality and specifications • Lower costs • Higher financial predictability • Certainty of supply • Well positioned to address niche markets • Economies of scale • Low carbon footprint 29 GLOBAL DEVELOPMENTS AS GROWTH DRIVERS Segment Specialty Chemicals Segment Basics & Inter - mediates © Alzchem Group AG / October 2026 POPULATION GROWTH LONGER LIFE EXPECTANCY SUSTAINA - BILITY CLIMATE CHANGE SAFETY & DEFENCE
Page 29
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries 30 © Alzchem Group AG / October 2026 MAIN PRODUCTS DESCRIPTION END - MARKETS SPECIALTY CHEMICALS A nutritional additive for poultry and pigs Feed additive Creapure ® , premium brand for creatine monohydrate as ingredient in sports & health nutrition Food supplements Dietary supplement with pure creatine Food supplements Creatine for health and food applications Food supplements Plant growth regulator used in fruit production Agriculture Additive for plant protection formulations Agriculture Plant growth regulator used in fruit production Agriculture Silicon nitride powder for ceramic applications Ceramics Highly purified form of guanidine salts Pharmaceuticals / API An organic compound widely used in agriculture and pharmaceuticals Agriculture and pharmaceuticals Hardeners and accelerators in powder. paste and liquid form Hardener & Accelerator Systems for Composite Materials Various applications incl. flotation agents and pharmaceutical raw materials Mining and pharmaceuticals Intermediates for explosives and agrochemical products Agriculture. Automotive. Defense
Page 30
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries 31 MAIN PRODUCTS DESCRIPTION END - MARKETS BASICS & INTERMEDIATES Calcium carbide - based mixtures for hot metal desulphurization Steel industry Fuel for airbags. key production of the intermediate product Automotive Versatile intermediate in various markets including the pharmaceutical industry P harmaceutical Agriculture Business fields in color, agro and pharmaceutical applications Pigments P harmaceutical Reduction of methane emissions during storage of manure Agriculture Special calcium cyanamide multi - effect fertilizer Agriculture OTHER & HOLDING Operation of the Trostberg Chemical Park (companies located at the site: Alzchem, BASF, Master Builders Solution, Sika, Firme nic h, Klüh Catering, VIACTIV) Site services Other activities not included in the "Specialty Chemicals" or "Basics & Intermediates" segments © Alzchem Group AG / October 2026
Page 31
100% 85% 70% 50% 30% 15% 100% 85% 50% 70% 35% 20% 100% 15% 30% 50% 70% 85% Primärfarben 100% 85% 35% 20% 50% 70% 100% 85% 70% 50% 35% 20% 35% 50% 70% 85% 100% 20% 100% 85% 35% 20% 50% 70% 20% 35% 50% 70% 85% 100% Sekundärfarben four two na GmbH 10.14% Staluna Trade a. s. 9.90% Löw SE 6.39% Free float 73.57% KEY SHARE DATA Share details as of October 27, 2026 32 SHAREHOLDER STRUCTURE © Alzchem Group AG / October 2026 As of June 2026: The information on the shareholders is based on the figures reported to us by them. Data regarding the free float are provided in accordance with section 5.8 of the Stoxx “DAX Equity Index Methodology Guide”. The information is based on published notifications of major holdings. Certain reported positions may reflect bank holdings for trading or hedging purposes and are not separately presented above. SHARES OUTSTANDING 10,176,335 LAST CLOSING PRICE EUR 161.60 MARKET CAPITALIZATION EUR 1.644,5 m TICKER ACT WKN A2YNT3 ISIN DE000A2YNT30 LISTING Frankfurt Stock Exchange – Prime Standard STOCK MARKET SEGMENT SDAX DESIGNATED SPONSOR LBBW ODDO BHF SE